Hemorrhaging during pregnancy;Blutungen während der schwangerschaft

Anaesthesist

Volumn 56, Issue 10, 2007, Pages 1075-1090

  Hofer, S ^a   Schreckenberger, R ^a   Heindl, B ^b   Gorlinger K ^c   Lier, H ^d   Maul, H ^a   Martin, E ^a   Weigand, M A ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY HOSPITAL ESSEN   (Germany)

^d UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Coagulation therapy; Hemorrhage during pregnancy; Hemostasis during pregnancy; Hyperfibrinolysis; Uterine atony

Indexed keywords

FIBRINOGEN;

ANTICOAGULATION; BLEEDING; DISEASE SEVERITY; EARLY DIAGNOSIS; FETUS OUTCOME; FIBRINOLYSIS; HEMOSTASIS; HUMAN; INTERDISCIPLINARY EDUCATION; MATERNAL MORTALITY; MEDICAL PRACTICE; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; THROMBOCYTE; UTERINE ATONY;

ADULT; FACTOR VIIA; FEMALE; FIBRINOLYSIS; HEMORRHAGE; HEMOSTASIS; HUMANS; INFANT, NEWBORN; PLACENTA DISEASES; PLATELET TRANSFUSION; POSTPARTUM HEMORRHAGE; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 35848967249     PISSN: 00032417     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00101-007-1261-2     Document Type: Review

References (70)

1. Ananth CV, Savitz DA (1994) Vaginal bleeding and adverse reproductive outcomes: a meta-analysis. Paediatr Perinat Epidemiol 8: 62-78
2. Astermark J, Donfield SM, DiMichele DM et al. (2007) A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study. Blood 109: 546-551
3. Axelsen SM, Henriksen TB, Hedegaard M et al. (1995) Characteristics of vaginal bleeding during pregnancy. Eur J Obstet Gynecol Reprod Biol 63: 131-134
4. Biron-Andreani C, Morau E, Schved JF et al. (2003) Amniotic fluid embolism with haemostasis complications: primary fibrinogenolysis or disseminated intravascular coagulation? Pathophysiol Haemost Thromb 33: 170-171
5. Bonn C, Wetzka B, Zahradnik HP (2002) The use of TEG with the roTEG in preeclampsia and HELLP syndrome. Hypertens Pregnancy [Suppl 1] 21: 80
6. Bremme KA (2003) Haemostatic changes in pregnancy. Best Pract Res Clin Haematol 16: 153-168
7. Catena C, Zingaro L, Casaccio D et al. (2000) Abnormalities of coagulation in hypertensive patients with reduced creatinine clearance. Am J Med 109: 556-561
8. Charbit B, Mandelbrot L, Samain E et al. (2007) The decrease of fibrinogen is an early predictor of the severity of postpartum hemorrhage. J Thromb Haemost 5: 266-273
9. Chowdhury P, Saayman AG, Paulus U et al. (2004) Efficacy of standard dose and 30 ml/kg fresh frozen plasma in correcting laboratory parameters of haemostasis in critically ill patients. Br J Haematol 125: 69-73
10. Clenney TL, Viera AJ (2004) Corticosteroids for HELLP (haemolysis, elevated liver enzymes, low platelets) syndrome. BMJ 329: 270-272
11. Collins PW (2003) Management of acquired haemophilia A - more questions than answers. Blood Coagul Fibrinolysis [Suppl 1] 14: S23-S27
12. Crochetiere C (2003) Obstetric emergencies. Anesthesiol Clin North Am 21: 111-125
13. Deneux-Tharaux C, Carmona E, Bouvier-Colle MH et al. (2006) Postpartum maternal mortality and cesarean delivery. Obstet Gynecol 108: 541-548
14. Dildy GA (2002) Postpartum hemorrhage: new management options. Clin Obstet Gynecol 45: 330-344
15. Eder AF, Herron R, Strupp A et al. (2007) Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross. Transfusion 47: 599-607
16. FitzGerald MP, Floro C, Siegel J et al. (1996) Laboratory findings in hypertensive disorders of pregnancy. J Natl Med Assoc 88: 794-798
17. Fonseca JE, Mendez F, Catano C et al. (2005) Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193: 1591-1598
18. Franchini M (2006) Postpartum acquired factor VIII inhibitors. Am J Hematol 81: 768-773
19. Franchini M, Lippi G, Franchi M (2007) The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage. BJOG 114: 8-15
20. Fuchs AR, Romero R, Keefe D et al. (1991) Oxytocin secretion and human parturition: pulse frequency and duration increase during spontaneous labor in women. Am J Obstet Gynecol 165: 1515-1523
21. Gai MY, Wu LF, Su QF et al. (2004) Clinical observation of blood loss reduced by tranexamic acid during and after caesarian section: a multi-center, randomized trial. Eur J Obstet Gynecol Reprod Biol 112: 154-157
22. Gerbasi FR, Bottoms S, Farag A et al. (1990) Increased intravascular coagulation associated with pregnancy. Obstet Gynecol 75: 385-389
23. Goldszmidt E, Davies S (2003) Two cases of hemorrhage secondary to amniotic fluid embolus managed with uterine artery embolization. Can J Anaesth 50: 917-921
24. Green D (2006) The management of acquired haemophilia. Haemophilia [Suppl 5] 12: 32-36
25. Hansch E, Chitkara U, McAlpine J et al. (1999) Pelvic arterial embolization for control of obstetric hemorrhage: a five-year experience. Am J Obstet Gynecol 180: 1454-1460
26. Hardy JF, Moerloose P de, Samama CM (2006) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth [Suppl 6] 53: S40-S58
27. Hatzopoulos FK (2005) Obstetric drug therapy. In: Koda-Kimble MA, Young LY, Kradjan WA et al. (eds) Applied therapeutics: the clinical use of drugs, 8th edn. Lippincott Williams & Wilkins, Philadelphia, p 126
28. Hay CR, Brown S, Collins PW et al. (2006) The diagnosis and management of factor VIII and IX inhibitors: a guideline from the United Kingdom Haemophilia Centre Doctors Organisation. Br J Haematol 133: 591-605
29. Heilmann L, Wild C, Hojnacki B et al. (2006) Successful treatment of life-threatening bleeding after cesarean section with recombinant activated factor VII. Clin Appl Thromb Hemost 12: 227-229
30. Heindl B, Delorenzo C, Spannagl M (2005) High dose fibrinogen administration for acute therapy of coagulopathy during massive perioperative transfusion. Anaesthesist 54: 787-790
31. Hellgren M (2003) Hemostasis during normal pregnancy and puerperium. Semin Thromb Hemost 29: 125-130
32. Holmes VA (2003) Changes in haemostasis during normal pregnancy: does homocysteine play a role in maintaining homeostasis? Proc Nutr Soc 62: 479-493
33. Holmes VA, Wallace JM (2005) Haemostasis in normal pregnancy: a balancing act? Biochem Soc Trans 33: 428-432
34. Huch A, Chaoui R (2004) Sectio caesarea: In: SchneiderH, Husslein P, Schneider KTM (Hrsg) Die Geburtshilfe, 2. Aufl. Springer, Berlin Heidelberg New York
35. Kam PC, Thompson SA, Liew AC (2004) Thrombocytopenia in the parturient. Anaesthesia 59: 255-264
36. Karalapillai D, Popham P (2007) Recombinant factor VIIa in massive postpartum haemorrhage. Int J Obstet Anesth 16: 29-34
37. Kobayashi T, Terao T, Maki M et al. (2001) Diagnosis and management of acute obstetrical DIC. Semin Thromb Hemost 27: 161-167
38. Koscielny J, Tempelhoff GF von, Ziemer S et al. (2004) A practical concept for preoperative management of patients with impaired primary hemostasis. Clin Appl Thromb Hemost 10: 155-166
39. Kretzschmar M, Zahm DM, Remmler K et al. (2003).,Anaphylactoid syndrome of pregnancy" Pathophysiologische und therapeutische Aspekte der Fruchtwasserembolie (.,anaphylactoid syndrome of pregnancy") anhand einer Kasuistik mit letalem Ausgang. Anaesthesist 52: 419-426
40. Krumnikl JJ, Böttiger BW, Strittmatter HJ et al. (2002) Complete recovery after 2 h of cardiopulmonary resuscitation following high-dose prostaglandin treatment for atonic uterine haemorrhage. Acta Anaesthesiol Scand 46: 1168-1170
41. Ku DH, Arkel YS, Paidas MP et al. (2003) Circulating levels of inflammatory cytokines (IL-1 beta and TNF-alpha), resistance to activated protein C, thrombin and fibrin generation in uncomplicated pregnancies. Thromb Haemost 90: 1074-1079
42. Letsky EA (2001) Disseminated intravascular coagulation. Best Pract Res Clin Obstet Gynaecol 15: 623-644
43. Lindoff C, Rybo G, Astedt B (1993) Treatment with tranexamic acid during pregnancy, and the risk of thrombo-embolic complications. Thromb Haemost 70: 238-240
44. Lockwood CJ (2006) Pregnancy-associated changes in the hemostatic system. Clin Obstet Gynecol 49: 836-843
45. Ojala K, Perala J, Kariniemi J et al. (2005) Arterial embolization and prophylactic catheterization for the treatment for severe obstetric hemorrhage. Acta Obstet Gynecol Scand 84: 1075-1080
46. Orlikowski CEP, Rocke DA, Murray WB et al. (1996) Thromboelastography changes in pre-eclampsia and eclampsia. Br J Anaesth 77: 157-161
47. Parnas M, Sheiner E, Shoham-Vardi I et al. (2006) Moderate to severe thrombocytopenia during pregnancy. Eur J Obstet Gynecol Reprod Biol 128: 163-168
48. Pelage J-P, Le Dref O, Jacob D et al. (1999) Selective arterial embolization of the uterine arteries in the management of intractable post-partum hemorrhage. Acta Obstet Gynecol Scand 78: 698-703
49. Pfanner G, Kilgert K (2006) Geburtshilfliche Blutungskomplikationen. Hämostaseologie [Suppl 1] 26: S56-S63
50. Poe MF (1959) Clot observation test for clinical diagnosis of clotting defects. Anesthesiology 20: 825-829
51. Prabu P, Parapia LA (2006) Bernard-Soulier syndrome in pregnancy. Clin Lab Haematol 28: 198-201
52. Ramanathan J, Bennett K (2003) Pre-eclampsia: fluids, drugs, and anesthetic management. Anesthesiol Clin North Am 21: 145-163
53. Roberts JM, Gammill HS (2005) Preeclampsia: recent insights. Hypertension 46: 1243-1249
54. Roberts HR, Monroe DM, Oliver JA et al. (1998) Newer concepts of blood coagulation. Haemophilia 4: 331-334
55. Rouse DJ, MacPherson C, Landon M et al. (2006) Blood transfusion and cesarean delivery. Obstet Gynecol 108: 891-897
56. Schuurmans N, Mackinnin C, Lane C et al. (2000) Prevention and management of postpartum haemorrhage. J Soc Obstet Gynaecol Can 88: 271-281
57. Segal S, Shemesh IY, Blumenthal R et al. (2003) Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa). Arch Gynecol Obstet 268: 266-267
58. Shafi T, Jeha MT, Black L et al. (1997) Severe aquired haemophilia A treated with recombinant factor VIIa. Br J Haematol 98: 910-912
59. Sharma SK, Philip J, Whitten CW et al. (1999) Assessment of changes in coagulation in parturients with pre-eclampsia using thromboelastography. Anesthesiology 90: 3485-3490
60. Silliman CC, Curtis BR, Kopko PM et al. (2007) Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model. Blood 109: 1752-1755
61. Smith JG, Merrill DC (2006) Oxytocin for induction of labor. Clin Obstet Gynecol 49: 594-608
62. Sobieszczyk S, Breborowicz GH, Platicanov V et al. (2006) Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use. Acta Obstet Gynecol Scand 85: 1239-1247
63. Toy P, Popovsky MA, Abraham E et al. (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33: 721-726
64. UNFPA (2003) Maternal mortality update 2002: a focus on emergency obstetric care. United Nations Population Fund, New York
65. Vincent J-L, Rossaint R, Riou B et al. (2006) Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding: a European perspective. Crit Care 10: 1-12
66. Weiner CP (1986) The obstetric patient and disseminated intravascular coagulation. Clin Perinatol 13: 705-717
67. Whitta RK, Cox DJ, Mallett SV (1995) Thrombelastography reveals two causes of haemorrhage in HELLP syndrome. Br J Anaesth 74: 464-468
68. Xenakis EM, Piper JM (1997) Chemotherapeutic induction of labour. A rational approach. Drugs 54: 61-68
69. Yang J, Savitz DA, Dole N et al. (2005) Predictors of vaginal bleeding during the first two trimesters of pregnancy. Paediatr Perinat Epidemiol 19: 276-283
70. Zelop CM, Harlow BL, Frigoletto FD (1993) Emergency peripartum hysterectomy. Am J Obstet Gynecol 168: 1443-1448